معرفی
PD Dr. Michael Veit is an Associate Professor (Privatdozent) at the Institute of Virology, School of Veterinary Medicine, Freie Universität Berlin, where he heads the independent Research Group Veit – Cell Biology of Viral Infections. He is a faculty member of the Center for Infection Medicine and participates in the Berlin Equine Virus Lab (BEVL).
Education & Training
- Doctorate (Dr. rer. nat.) in Virology/Biochemistry – exact institution not stated in text.
- Post-doctoral qualification (Privatdozent) awarded by Freie Universität Berlin.
Research Focus
Veit’s laboratory investigates the molecular and cellular biology of enveloped RNA viruses, with emphasis on virus–host membrane interactions and post-translational lipid modifications (S-acylation/palmitoylation). His group combines reverse genetics, live-cell imaging, mass spectrometry and structural approaches to dissect how viral glycoproteins are modified, trafficked and assembled into infectious particles. Model pathogens include influenza A, B, C and D viruses, coronaviruses (SARS-CoV-2, MERS-like CoVs, PHEV, PDCoV), arteriviruses (PRRSV, EAV), alphaviruses (Getah, CHIKV-like), and other emerging zoonotic agents.
Publication Trends
From 2020 to 2025 Veit has published >30 high-impact articles that cluster around four major themes: (i) coronavirus surveillance and zoonotic risk assessment, (ii) mechanistic dissection of protein acylation in influenza and arteriviruses, (iii) structure-function analysis of viral entry receptors (ACE2, LDLR), and (iv) development of reverse-genetic tools and reporter viruses for antiviral screening.
Grants & Collaborative Networks
- Ongoing third-party funded projects coordinated by Veit are not explicitly listed in the text, but the continuous publication output and mention of “Current Collaborations” imply active grant support.
- He collaborates closely with other FU Berlin groups (Osterrieder, Kaufer, Azab) and international partners on coronavirus and influenza consortia.
Laboratory & Teams
The Research Group Veit comprises post-docs, PhD students and technicians working in BSL-2 and BSL-3 facilities at the Institute of Virology. Core platforms include confocal & FLIM microscopy, quantitative proteomics, and reverse-genetics suites for segmented RNA viruses.
